Abstract
There is increasing evidence that amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) lie on a clinical, pathological and genetic continuum with patients of one disease exhibiting features of the other. Nevertheless, to date, the underlying grey matter and white matter changes across the ALS-FTD disease continuum have not been explored. In this study fifty-three participants with ALS (n = 10), ALS-FTD (n = 10) and behavioural variant FTD (bvFTD; n = 15) as well as controls (n = 18), underwent detailed clinical assessment plus structural imaging using voxel-based morphometry (VBM) and diffusion tensor imaging (DTI) analysis of magnetic resonance brain imaging to examine grey and white matter differences and commonalities across the continuum. Importantly, patient groups were matched for age, education, gender and disease duration. VBM and DTI results showed that changes in the ALS group were confined mainly to the motor cortex and anterior cingulate as well as their underlying white matter tracts. ALS-FTD and bvFTD showed widespread grey matter and white matter changes involving frontal and temporal lobes. Extensive prefrontal cortex changes emerged as a marker for bvFTD compared to other subtypes, while ALS-FTD could be distinguished from ALS by additional temporal lobe grey and white matter changes. Finally, ALS could be mainly distinguished from the other two groups by corticospinal tract degeneration. The present study shows for the first time that FTD and ALS overlap in anterior cingulate, motor cortex and related white matter tract changes across the whole continuum. Nevertheless, frontal and temporal atrophy as well as corticospinal tract degeneration emerged as marker for subtype classification, which will inform future diagnosis and target disease management across the continuum.
Highlights
Amyotrophic lateral sclerosis (ALS) and Frontotemporal dementia (FTD) are multisystem neurodegenerative disorders [1,2], which overlap at a clinical and pathological level [3,4,5]
Post hoc comparisons using Tukey HSD tests indicated that both the amyotrophic lateral sclerosis (ALS)-frontotemporal dementia (FTD) and behavioural variant FTD (bvFTD) groups performed significantly worse than controls (p,.001) but there was no significant difference between ALS and controls (p.1), and ALS patients performed better than ALSFTD and bvFTD groups (p’s,.01)
Of particular interest was the finding of motor cortex atrophy and corticospinal degeneration in bvFTD, in keeping with a recent report of TMS motor hyperexcitability in a high proportion of FTD patients [39]
Summary
Amyotrophic lateral sclerosis (ALS) and Frontotemporal dementia (FTD) are multisystem neurodegenerative disorders [1,2], which overlap at a clinical and pathological level [3,4,5]. Whilst a proportion of patients presenting with ALS manifest cognitive and behavioral changes which may be severe enough in some instances to reach criteria for frank FTD (10–15%) [6,7], a subgroup of patients with FTD develops features of ALS (15%) [8] This continuum has been reinforced on two levels: i) pathological - TAR DNA binding protein 43 kD (TDP-43) is the principal protein inclusion in ALS and in a subgroup of FTD cases [9,10]; and recently ii) genetic – by identifying a unique expansion in the intron of C9ORF72 on chromosome 9 (9p21) in families affected by ALS, FTD or ALS-FTD. Similar to the sporadic FTD and ALS, the average age of presentation was in the fifties, but there was a wide spread of presentation age (32–76 years old) [16,17,18,19,20]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.